The Lancet - ARUBA: "Medical Management With or Without Interventional Therapy for Unruptured Brain Arteriovenous Malformations"

The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations remains uncertain.

New York, NY
 – November 20, 2013  –– 

A randomised trial of unruptured Brain Arteriovenous malformations (ARUBA) aims to compare the risk of death and symptomatic stroke in patients with an unruptured brain arteriovenous malformation who are allocated to either medical management alone or medical management with interventional therapy.
Read More